Resideo director Jack Lazar receives 901-share stock grant
Resideo Technologies director Jack R. Lazar reported receiving an equity grant of 901 shares of common stock effective 01/01/2026 at a price of $35.36 per share.
Rhea-AI Filing Summary
Resideo Technologies director Jack R. Lazar reported receiving an equity grant of 901 shares of common stock effective 01/01/2026 at a price of $35.36 per share. This was issued under the company’s 2018 Stock Plan for Non-Employee Directors in lieu of annual cash retainer fees. The stock units are fully vested upon grant and will be settled in a lump sum of common shares after his service as a director ends. Following this grant, Lazar beneficially owns 115,782 shares of Resideo common stock directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 901 | $35.36 | $32K |
Footnotes (1)
- F1. Issued under the 2018 Stock Plan for Non-Employee Directors of Resideo Technologies, Inc. in lieu of annual cash retainer fees and to be settled by issuance of shares of Common Stock in a lump sum following termination of service as a director. These stock units are fully vested upon grant.
FAQ
What insider transaction did Resideo Technologies (REZI) report for Jack R. Lazar?
Resideo Technologies reported that director Jack R. Lazar received an equity grant of 901 shares of common stock effective 01/01/2026 at a price of $35.36 per share.
When will the stock units granted to Jack R. Lazar by Resideo Technologies (REZI) be settled?
The stock units will be settled by issuing shares of Resideo common stock in a lump sum following Jack R. Lazar’s termination of service as a director.
Are the Resideo Technologies (REZI) director stock units fully vested?
Yes. The filing states that these stock units granted to Jack R. Lazar are fully vested upon grant.
AI-generated analysis. How Rhea-AI works. Not financial advice.